HepaGam B
Manufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2 Holzman St Science Park, Rehovot, Cent...Website
www.hepagamb.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About HepaGam B
Kamada Pharmaceuticals specializes in the development and manufacturing of therapeutic products, particularly focusing on Hepatitis B immune globulin (HBIg) for preventing hepatitis B virus recurrence in liver transplant patients and providing post-exposure prophylaxis. Their flagship product, HepaGam B, is FDA-approved for use in HBsAg-positive patients and is administered via intravenous infusion or intramuscular injection. The company targets healthcare professionals in the U.S. who are involved in liver transplantation and infectious disease management. Kamada emphasizes safety and efficacy, providing important safety information and monitoring guidelines for their products.Explore more
Popular SearchesHepaGam B®SaolHepaGam BSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is HepaGam B your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at HepaGam B
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once HepaGam B has new funding data
HepaGam B, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if HepaGam B had a recent Job posting/layoffs
Check out if HepaGam B is spiking on competitors!
Check if HepaGam B has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on HepaGam B recently announced quarterly report
Product Launch: Get notified when HepaGam B launches new products
Recommended Actions
Find VP level buyers at HepaGam B
Find more new buyers
Compare Similar Companies to HepaGam B
Compare insights from companies similar to HepaGam B, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
HepaGam B
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
HepaGam B is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
HepaGam B is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about HepaGam B.
HepaGam B Tech Stack
A closer look at the technologies used by HepaGam B
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding HepaGam B
Sign Up For FreeTo access detailed company insights
Kamada Pharmaceuticals specializes in the development and manufacturing of therapeutic products, particularly focusing on Hepatitis B immune globulin (HBIg) for preventing hepatitis B virus recurrence in liver transplant patients and providing post-exposure prophylaxis. Their flagship product, HepaGam B, is FDA-approved for use in HBsAg-positive pa... Read More
